Role of Retinol-binding Protein 4 as an Early Biomarker for Diabetic Nephropathy in Type 2 Diabetic Patients. Medico Legal Update, [S. l.], v. 21, n. 2, p. 578–583, 2021. DOI: 10.37506/mlu.v21i2.2744. Disponível em: https://ijop.net/index.php/mlu/article/view/2744. Acesso em: 20 may. 2026.